NCT03389347 2026-05-08High Throughput Drug Sensitivity and Genomics Data in Developing Individualized Treatment in Patients With Relapsed or Refractory Multiple Myeloma or Plasma Cell LeukemiaUniversity of WashingtonPhase NA Active not recruiting40 enrolled 7 charts